RT Journal Article
SR Electronic
T1 Modelling long-term COVID-19 hospital admission dynamics using immune protection waning data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.16.22275130
DO 10.1101/2022.05.16.22275130
A1 Reyné, Bastien
A1 Sofonea, Mircea T.
A1 Alizon, Samuel
YR 2022
UL http://medrxiv.org/content/early/2022/06/15/2022.05.16.22275130.abstract
AB Immune waning is key to the timely anticipation of COVID-19 long-term dynamics. We assess the impact of periodic vaccination campaigns using a compartmental epidemiological model with multiple age structures and parameterised using empiric time-dependent vaccine protection data. Despite the uncertainty inherent to such scenarios, we show that vaccination campaigns decreases the yearly number of COVID-19 admissions. However, especially if restricted to individuals over 60 years old, vaccination on its own seems insufficient to prevent thousands of hospital admissions and it suffers the comparison with non-pharmaceutical interventions aimed at decreasing infection transmission. The combination of such interventions and vaccination campaigns appear to provide the greatest reduction in hospital admissions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBR is funded by the Ministere de l'Enseignement Superieur et de la Recherche.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe scripts are available on demand.